Brief: Bionano Genomics Receives Notice Of Delisting Or Failure To Satisfy Continued Listing Rule From Nasdaq
02/06/2023 21:22
June 2 (Reuters) - Bionano Genomics Inc BNGO.O :
* BIONANO GENOMICS - ON MAY 30, RECEIVED NOTICE OF DELISTING
OR
FAILURE TO SATISFY CONTINUED LISTING RULE OR STANDARD; TRANSFER
OF LISTING FROM NASDAQ
Source text for Eikon: ID:
Further company coverage: BNGO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bionano Genomics
See all newsBionano Genomics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Bionano Genomics Q2 revenue rises on increased clinical adoption
Brief: Bionano Genomics Q2 Revenue USD 8.2 Million
Bionano Genomics, Inc. expected to post a loss of 68 cents a share - Earnings Preview
Bionano Genomics Q1 revenue up 4%, margin improves; to retire convertible debt